These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18265297)

  • 21. Mapping antibody binding sites on cytochrome c with synthetic peptides: are results representative of the antigenic structure of proteins?
    Schwab C; Twardek A; Lo TP; Brayer GD; Bosshard HR
    Protein Sci; 1993 Feb; 2(2):175-82. PubMed ID: 7680266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of multiple antigenic peptides (MAPs)-strategies and limitations.
    Kowalczyk W; Monsó M; de la Torre BG; Andreu D
    J Pept Sci; 2011 Apr; 17(4):247-51. PubMed ID: 21391284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components.
    Seebach D; Beck AK; Bierbaum DJ
    Chem Biodivers; 2004 Aug; 1(8):1111-239. PubMed ID: 17191902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An efficient preparation of N-methyl-alpha-amino acids from N-nosyl-alpha-amino acid phenacyl esters.
    Leggio A; Belsito EL; De Marco R; Liguori A; Perri F; Viscomi MC
    J Org Chem; 2010 Mar; 75(5):1386-92. PubMed ID: 20121053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the fine structure of the antigenic determinants of the transmembrane protein in the HIV coat with chemically modified synthetic peptides.
    Andreev SM; Meshcheryakova DB; Vafina MG; Az'muko AA; Sidorova MV; Khaitov RM
    Biomed Sci; 1991; 2(3):271-8. PubMed ID: 1751760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody responses of chimpanzees immunized with synthetic peptides corresponding to full-length V3 hypervariable loops of HIV-1 envelope glycoproteins.
    Neurath AR; Jiang S; Strick N; Kolbe H; Kieny MP; Muchmore E; Girard M
    AIDS Res Hum Retroviruses; 1991 Oct; 7(10):813-23. PubMed ID: 1720628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acid cleavage/deprotection in Fmoc/tBu solid-phase peptide synthesis.
    Dick F
    Methods Mol Biol; 1994; 35():63-72. PubMed ID: 7894609
    [No Abstract]   [Full Text] [Related]  

  • 28. [Production and characterization of human antirenin antibodies prepared with synthetic immunogens].
    Galen FX; Evin G; Carelli C; Bouhnik J; Michel JB; Ferhentz JA; Le N'Guyen D; Seyer R; Carlson WD; Haber E
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():199-201. PubMed ID: 2461182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reactivity of anti-peptide and anti-poliovirus type 3 monoclonal antibodies with synthetic peptides.
    Ferguson M; Reed SE; Minor PD
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2527-31. PubMed ID: 2431104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic properties of the second loop of transforming growth factor alpha by synthetic peptides.
    Bahr J; Lüning B
    Acta Chem Scand (Cph); 1992 Mar; 46(3):266-70. PubMed ID: 1581123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of peptide bioconjugates.
    Hudecz F
    Methods Mol Biol; 2005; 298():209-23. PubMed ID: 16044549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of two chemically modified peptide epitopes for the class I MHC protein HLA-B*2705.
    Jones MA; Hislop AD; Snaith JS
    Org Biomol Chem; 2006 Oct; 4(20):3769-77. PubMed ID: 17024283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus.
    Meloen RH; Puyk WC; Meijer DJ; Lankhof H; Posthumus WP; Schaaper WM
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():305-14. PubMed ID: 2434606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of polyacrylamide-based peptide synthesis resins for the generation of antipeptide antibodies.
    McMurray JS
    Biopolymers; 1998; 47(5):405-11. PubMed ID: 9973868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of antibodies to alpha(181-192) peptides of neuronal nicotinic acetylcholine receptor coupled to protein carriers in different orientations.
    Skok MV; Lykhmus OY; Bobrovnik SO; Solodova OV; Tzartos SJ; Tsouloufis T; Vanderesse R; Marraud M
    Ukr Biokhim Zh (1999); 2002; 74(4):54-60. PubMed ID: 14964862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production and characterization of peptide antibodies.
    Trier NH; Hansen PR; Houen G
    Methods; 2012 Feb; 56(2):136-44. PubMed ID: 22178691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-PorA antibodies elicited by immunization with peptides conjugated to P64k.
    Sardiñas G; González S; Garay HE; Nazábal C; Reyes O; Silva R
    Biochem Biophys Res Commun; 2000 Oct; 277(1):51-4. PubMed ID: 11027638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 14C-labeling of synthetic peptides.
    Chersi A; Trinca ML; Camera M
    J Immunol Methods; 1988 Jun; 110(2):271-3. PubMed ID: 3379315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in solid-phase peptide synthesis and preparation of antibodies to synthetic peptides.
    Plaue S; Muller S; Briand JP; Van Regenmortel MH
    Biologicals; 1990 Jul; 18(3):147-57. PubMed ID: 2257127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic peptides for the immunodiagnosis of human diseases.
    Gómara MJ; Haro I
    Curr Med Chem; 2007; 14(5):531-46. PubMed ID: 17346145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.